GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (OTCPK:LVZPF) » Definitions » Scaled Net Operating Assets

LVZPF (Livzon Pharmaceutical Group) Scaled Net Operating Assets : 0.33 (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Livzon Pharmaceutical Group Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Livzon Pharmaceutical Group's operating assets for the quarter that ended in Sep. 2024 was $1,993 Mil. Livzon Pharmaceutical Group's operating liabilities for the quarter that ended in Sep. 2024 was $830 Mil. Livzon Pharmaceutical Group's Total Assets for the quarter that ended in Jun. 2024 was $3,525 Mil. Therefore, Livzon Pharmaceutical Group's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.33.


Livzon Pharmaceutical Group Scaled Net Operating Assets Historical Data

The historical data trend for Livzon Pharmaceutical Group's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Scaled Net Operating Assets Chart

Livzon Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.33 0.38 0.33 0.29

Livzon Pharmaceutical Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.31 0.31 0.28 0.33

Competitive Comparison of Livzon Pharmaceutical Group's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Livzon Pharmaceutical Group's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's Scaled Net Operating Assets falls into.



Livzon Pharmaceutical Group Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Livzon Pharmaceutical Group's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(1909.934-859.448)/3567.017
=0.29

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3507.581 - 1597.647
=1909.934

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1439.473 - 227.137 - 352.888
=859.448

Livzon Pharmaceutical Group's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(1992.673-829.933)/3525.433
=0.33

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3520.253 - 1527.58
=1992.673

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1409.485 - 59.243 - 520.309
=829.933

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Livzon Pharmaceutical Group Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Livzon Pharmaceutical Group Business Description

Traded in Other Exchanges
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment in PRC which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group Headlines

No Headlines